Evaluation of a pilot program for managing chronic diseases in Hong Kong

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Chronic Disease Co-Care (CDCC) Pilot Scheme aims to enhance the early screening and management of hypertension and diabetes in Hong Kong. This 12-month cohort study will assess the quality of care, feasibility, acceptability, effectiveness, and cost-effectiveness of the program. Participants will include individuals aged 45 and older who are registered with District Health Centres, and their health outcomes will be compared to a control group of non-participants. Data will be collected through questionnaires and surveys to evaluate participant experiences and healthcare provider adherence to care standards.

Why it matters

Who can join: the full rules

Inclusion Criteria of interventional group:

* Hong Kong residents
* Aged ≥45 years
* Registered as a member of DHC/DHC Express
* Provided informed consent on sharing their data in the electronic Health Record Sharing System
* Provided consent to join the CDCC Pilot Scheme Terms and Conditions.

Exclusion Criteria of interventional group:

* With known history of DM or HT

Inclusion Criteria of comparison group:

* Hong Kong residents
* Aged ≥45 years
* Provided informed consent for the study.

Exclusion Criteria of comparison group:

* Without known history of DM or HT

Where it's running

• Jockey Club Building for Interdisciplinary Research 5 Sassoon Road, Pok Fu Lam, HONG KONG
  Hong Kong, Hong Kong Recruiting

Study contacts

• Study coordinator: Eric Yuk Fai Wan
• Email: yfwan@hku.hk
• Phone: 852 2831 5057

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• Taining Golden Lake comprehensive chronic disease management program

  This project will build a large cohort of adults in Taining County to collect health data and try to create a county-level chronic disease management model for people with hypertension, diabetes, dyslipidemia, and other long-term conditions.

  Recruiting First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian · NCT07308314

• Vicadrostat with empagliflozin for people with type 2 diabetes, high blood pressure, and heart disease

  This trial will test whether adding vicadrostat to empagliflozin lowers cardiovascular risk in adults who have type 2 diabetes, high blood pressure, and existing cardiovascular disease but no history of heart failure.

  Recruiting at 1096 sites Phase 3 Boehringer Ingelheim · Anniston, Alabama and 1141 other locations · NCT07064473

• Substituting high- with low-ultra-processed soy protein foods within a guideline-based diet for cardiometabolic health

  This study tests whether a 12-week digital diet program with extra fruits and vegetables, combined with either low- or high-ultra-processed soy protein foods, can lower systolic blood pressure in adults with hypertension and obesity, about half of whom have type 2 diabetes.

  Recruiting University of Toronto · Toronto, Ontario · NCT06907862

• County-based integrated cardiovascular care program using risk-stratified pathways

  This project will test whether a county-based team care program that uses cardiovascular risk levels, stronger education, financial incentives, and shared health records helps adults 40–70 with hypertension or type 2 diabetes get better treatment and control.

  Recruiting at 3 sites Peking University · Sanming, Fujian and 2 other locations · NCT06302127

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.